www.asiaone.com – MashupMD

Mashup Score: 2

AsiaOne - 3 month(s) ago

TOKYO, Jan 26, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has submitted a New Drug Application (NDA) for ultrahigh-dose mecobalamin (development code: E0302) for the indication of amyotrophic lateral sclerosis (ALS) to the Pharmaceuticals and Medical Devices Agency (PDMA) in Japan. In May 2022, ultrahigh-dose mecobalamin received orphan drug designation by the Ministry of…

Source: www.asiaone.com

Categories: General Medicine News, Rare Disease

Tweet Tweets with this article
- alsadvocacy
  
  https://t.co/ecbEGc1Svg

Mashup Score: 0

AsiaOne - 10 month(s) ago

KUALA LUMPUR, Malaysia and SINGAPORE, July 20, 2023 /PRNewswire/ — SayHeart, an inventive start-up, is set to redefine the healthcare industry with its AI-powered technology that simplifies convoluted health data into comprehensible narratives. Employing Generative AI, SayHeart has devised an algorithm that seamlessly translates medical jargon, health reports, and complex imaging into visual, easily digestible content. This ground-breaking…

Source: www.asiaone.com

Categories: Healthcare Professionals, Latest Headlines

Tweet Tweets with this article
- Sid_Healthcare
  
  #Malaysia #startup SayHeart uses #generativeAI to simplify convoluted health data into comprehensible narratives - aims to democratize health information, empower individuals, and unburden healthcare professionals from administrative load. https://t.co/A9X7bQq41B